Literature DB >> 7965815

The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells.

Q Y Liu1, E Karpinski, P K Pang.   

Abstract

The activation of alpha-1 adrenoceptors in adult rat ventricular cells results in the reduction of the transient outward K+ current, but does not affect Ca++ currents. In this study, using neonatal rat ventricular cells, the alpha-1 adrenergic receptor agonist phenylephrine increased the long-lasting (L-type) Ca++ channel current (dihydropyridine-sensitive) and the increase was concentration-dependent. Phenylephrine did not, however, modulate the transient-type (T-type) Ca++ channel current. The alpha-1 effect of phenylephrine was reversed or abolished by prazosin, an alpha-1 antagonist. The alpha-2 agonist clonidine had no effect on the L-type current. Yohimbine, an alpha-2 antagonist, and propranolol, a beta antagonist, did not inhibit the effect of phenylephrine on L-type current. The effect of phenylephrine was abolished by pretreatment with WB4101, an alpha-1A antagonist, but not by chloroethylclonidine, an alpha-1B antagonist. In addition, norepinephrine also increased the L-type current in the presence of propranolol and this effect was reversed by washout. These observations suggest that phenylephrine increased the L-type Ca++ channel current specifically through the activation of alpha-1A adrenergic receptors in neonatal rat ventricular myocytes. This may explain in part the increase in the plateau phase of the action potential and the positive inotropic response of the neonatal myocardium to phenylephrine. This is the first description of an increase in L-type Ca++ current by alpha-1A adrenoceptor activation in neonatal rat ventricular myocytes, and this effect is different from that reported in adult rat myocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965815

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.

Authors:  A Calderone; C M Thaik; N Takahashi; D L Chang; W S Colucci
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Efficient experimental design and analysis of real-time PCR assays.

Authors:  Kwokyin Hui; Zhong-Ping Feng
Journal:  Channels (Austin)       Date:  2013-03-19       Impact factor: 2.581

3.  Distinct QTLs are linked to cardiac left ventricular mass in a sex-specific manner in a normotensive inbred rat inter-cross.

Authors:  Bastien Llamas; Zhibin Jiang; Marie-Line Rainville; Sylvie Picard; Christian F Deschepper
Journal:  Mamm Genome       Date:  2005-10-20       Impact factor: 2.957

4.  Phenylephrine acts via IP3-dependent intracellular NO release to stimulate L-type Ca2+ current in cat atrial myocytes.

Authors:  Y G Wang; E N Dedkova; X Ji; L A Blatter; S L Lipsius
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182

Review 5.  Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Wendy Keung; Kenneth R Boheler; Ronald A Li
Journal:  Stem Cell Res Ther       Date:  2014-01-28       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.